Asensus Surgical Inc (ASXC)
0.2561
0.00 (0.00%)
USD |
NYAM |
Apr 17, 16:00
0.263
+0.01
(+2.69%)
After-Hours: 20:00
Asensus Surgical SG&A Expense (Quarterly): 7.773M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 7.773M |
September 30, 2023 | 8.709M |
June 30, 2023 | 9.573M |
March 31, 2023 | 10.02M |
December 31, 2022 | 8.614M |
September 30, 2022 | 8.468M |
June 30, 2022 | 8.594M |
March 31, 2022 | 9.252M |
December 31, 2021 | 9.155M |
September 30, 2021 | 9.108M |
June 30, 2021 | 7.41M |
March 31, 2021 | 7.045M |
December 31, 2020 | 6.484M |
September 30, 2020 | 6.598M |
June 30, 2020 | 6.52M |
March 31, 2020 | 7.602M |
December 31, 2019 | 9.388M |
September 30, 2019 | 12.79M |
June 30, 2019 | 12.36M |
March 31, 2019 | 12.23M |
December 31, 2018 | 11.77M |
September 30, 2018 | 9.505M |
June 30, 2018 | 9.673M |
March 31, 2018 | 8.646M |
December 31, 2017 | 9.123M |
Date | Value |
---|---|
September 30, 2017 | 7.448M |
June 30, 2017 | 6.468M |
March 31, 2017 | 6.772M |
December 31, 2016 | 6.474M |
September 30, 2016 | 5.367M |
June 30, 2016 | 4.201M |
March 31, 2016 | 3.922M |
December 31, 2015 | 3.918M |
September 30, 2015 | 2.175M |
June 30, 2015 | 2.363M |
March 31, 2015 | 2.23M |
December 31, 2014 | 1.388M |
September 30, 2014 | 1.937M |
June 30, 2014 | 2.374M |
March 31, 2014 | 2.02M |
December 31, 2013 | 1.509M |
September 30, 2013 | 1.716M |
June 30, 2013 | 1.242M |
March 31, 2013 | 1.197M |
December 31, 2012 | 1.319M |
September 30, 2012 | 1.802M |
June 30, 2012 | 1.068M |
March 31, 2012 | 0.915M |
December 31, 2011 | 0.679M |
September 30, 2011 | 0.506M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
6.484M
Minimum
Dec 2020
12.79M
Maximum
Sep 2019
8.708M
Average
8.614M
Median
Dec 2022
SG&A Expense (Quarterly) Benchmarks
Glaukos Corp | 63.03M |
Perspective Therapeutics Inc | 1.694M |
Retractable Technologies Inc | 4.158M |
Xtant Medical Holdings Inc | 20.45M |
Catheter Precision Inc | 2.729M |